Medical biochemistry laboratory, General Hospital Varaždin, Varaždin, Croatia.
Department of transfusion medicine, General Hospital Pula, Pula, Croatia.
Biochem Med (Zagreb). 2020 Jun 15;30(2):020705. doi: 10.11613/BM.2020.020705. Epub 2020 Apr 15.
Serum samples of haemodialysed patients collected through vascular access devices, central venous catheter (CVC) can contain residual heparin, which can cause incomplete clotting and consequently fibrinogen interference in serum protein electrophoresis (SPE). We hypothesized that this problem may be overcome by addition of thrombin and aimed to find a simple thrombin-based method for fibrinogen interference removal.
Blood samples of 51 haemodialysed patients with CVC were drawn through catheter into Clot Activator Tube (CAT) and Rapid Serum Tube Thrombin (RST) vacutainers (Becton Dickinson, New Jersey, USA) following the routine hospital protocols and analysed with gel-electrophoresis (Sebia, Lisses, France). Samples were redrawn in the CAT tubes and re-analysed after being treated with thrombin using two methods: transferring CAT serum into RST vacutainer and treatment of CAT serum with fibrinogen reagent (Multifibren U, Siemens, Marburg, Germany).
Direct blood collection in RST proved to be slightly more efficient than CAT in removing the interfering band in beta fraction (CAT removed 6/51 and RST removed 12/51, P = 0.031). Transferring CAT serum into the RST vacutainer proved to be more efficient for subsequent removal of interfering band from CAT serum than the addition of fibrinogen reagent (39/45 0/45 samples with efficiently removed interfering band, P < 0.001).
Fibrinogen interference caused by incomplete clotting because of residual heparin can be overcome by addition of thrombin. Transferring CAT serum into the RST vacutainer was the most efficient method.
通过血管通路装置(中央静脉导管 [CVC])收集的血液透析患者的血清样本可能含有残留的肝素,这可能导致不完全凝结,并因此导致血清蛋白质电泳(SPE)中的纤维蛋白原干扰。我们假设通过添加凝血酶可以克服这个问题,并旨在找到一种简单的基于凝血酶的方法来去除纤维蛋白原干扰。
按照常规医院方案,通过导管将 51 例 CVC 血液透析患者的血液样本抽取到 Clot Activator Tube(CAT)和 Rapid Serum Tube Thrombin(RST)真空管(Becton Dickinson,新泽西州,美国)中,并进行凝胶电泳分析(Sebia,Lisses,法国)。在 CAT 管中重新抽取样本,并在使用两种方法用凝血酶处理后重新分析:将 CAT 血清转移到 RST 真空管中和用纤维蛋白原试剂(Multifibren U,Siemens,Marburg,德国)处理 CAT 血清。
直接在 RST 中采血在去除β 区的干扰带方面略优于 CAT(CAT 去除了 6/51,RST 去除了 12/51,P = 0.031)。与添加纤维蛋白原试剂相比,将 CAT 血清转移到 RST 真空管中更有效地去除 CAT 血清中的干扰带(39/45 样本的干扰带被有效去除,0/45 样本的干扰带未被去除,P < 0.001)。
由于残留肝素导致的不完全凝结引起的纤维蛋白原干扰可以通过添加凝血酶来克服。将 CAT 血清转移到 RST 真空管中是最有效的方法。